Highly refractory epilepsy in a poorly defined sample
Gomez-Alonso, J.; Bellas-Lamas, P.; Fraga-Bau, A.
Revista de Neurologia 55(2): 128
2012
ISSN/ISBN: 1576-6578 PMID: 22760776 Document Number: 660051
Document emailed within 1 workday
Related Documents
Sánchez-Alvarez, J.C.; Altuzarra-Corral, A.; Mercadé-Cerdá, J.M.; Casado-Chocán, J.L.; Moreno-Alegre, V.; Rufo-Campos, M.; Camino-León, R.; Galán-Barranco, J.M.; Pita-Calandre, E.; Ramos-Lizana, J.; Serrano-Castro, P.J. 2005: The Andalusia Epilepsy Society's Guide to Epilepsy Therapy 2005: IV. General principles of antiepileptic polytherapy and therapeutic strategies in refractory epilepsy Revista de Neurologia 40(12): 743-7502004: Fluoroquinolones in children: poorly defined risk of joint damage Prescrire International 13(73): 184-186
Oria, A. 1998: Caroli disease: a therapeutic dilemma in a poorly defined disease Acta Gastroenterologica Latinoamericana 28(2): 227
Uono, K. 1974: A definition of refractory illness-various clinical problems concerning the legally defined diseases Nursing Technique 20(11): 9-13
Scharfstein, J.; Rodrigues, M.M.; Alves, C.A.; de Souza, W.; Previato, J.O.; Mendonça-Previato, L. 1983: Trypanosoma cruzi: description of a highly purified surface antigen defined by human antibodies Journal of Immunology 131(2): 972-976
Badaro, R.; Lobo, I.; Nakatani, M.; Muiños, A.; Netto, E.M.; Coler, R.N.; Reed, S.G. 2001: Successful use of a defined antigen/GM-CSF adjuvant vaccine to treat mucosal Leishmaniasis refractory to antimony: A case report Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 5(4): 223-232
Gueguen, B. 1998: Refractory epilepsy Presse Medicale 27(39): 2036-2042
Zhu, G.-X.; Ding, M.-P.; Xiao, B.; Wang, D.-X.; Wang, D.-S.; Pan, Y.-Z.; Zhao, Q.-C.; Pan, Y.-F.; Ma, G.-Y.; Hong, Z.; Lü, C.-Z. 2005: Curative effect of gabapentin on refractory epilepsy Zhonghua Yi Xue Za Zhi 85(2): 92-95
Novy, J.; Pollo, C.; Schaller, K.; Vulliémoz, S. 2010: "Palliative" surgical procedures in refractory epilepsy Revue Medicale Suisse 6(247): 916; 918-920
Caviedes, B.E.; Herranz, J.L.; Arteaga, R.; Armijo, J.A. 1999: In children with refractory epilepsy: vigabatrin or lamotrigine? Revista de Neurologia 28(5): 444-448
Pinto, A.; Sander, J.W. 2003: Levetiracetam: a new therapeutic option for refractory epilepsy International Journal of Clinical Practice 57(7): 616-621
Marszał, E.; Jamroz, E.; Szwed-Białozyt, B.; Wojaczyńska-Stanek, K.; Adamek, D.; Kluczewska, E. 2000: Cerebral tumors as a cause of refractory epilepsy in children Neurologia i Neurochirurgia Polska 34(Suppl 1): 233-241
Lischka, A.; Herkner, K.; Pollak, A. 1990: Neuroimmunologic parameters in therapy refractory epilepsy in children Wiener Klinische Wochenschrift 102(8): 227-230
2007: Zonisamide: new drug. No advantage in refractory partial epilepsy Prescrire International 16(89): 95-97
Paice, B.J.; Gray, J.M.; Chambers, A.M.; Stewart, M.J.; Durward, W.F.; Lawson, D.H. 1985: The anticonvulsant clinic: its value in the long-term management of refractory epilepsy Health Bulletin 43(1): 33-39
Salinas-Torres, V.M.; Domínguez, M.G.; Ornelas-Arana, M.L.; Rivera, H. 2013: Callosotomy in a girl with refractory epilepsy and Smith-Magenis syndrome Genetic Counseling 24(2): 239-242
Arévalo-Sáenz, A.; Torres, C.V.; Pastor, J.ús.; Alonso-Cerezo, C.ón.; Sola, R.G. 2015: Stimulation of the centromedian nucleus in refractory epilepsy associated to ring chromosome 20 Revista de Neurologia 60(12): 548-552
Stefan, H.; Pauli, E.; Eberhard, F.; Ugrinovich, R.; Buchfelder, M. 1996: "Tailoring" resections in drug refractory temporal lobe epilepsy Der Nervenarzt 67(4): 306-310
de Saint-Martin, A.; Hirsch, E. 2004: Refractory partial epilepsy: what are the neuropediatrician's criteria for drug resistance? Revue Neurologique (Paris) 160(Special Issue 1): 5s43-5s47
Ogawa, K.; Iyoda, K. 2013: The effectiveness of lamotrigine in a case of ring chromosome 14 with refractory epilepsy No to Hattatsu 45(5): 379-382